SkinBioTherapeutics Announces Holding Change
Why we think this is neutral
This RNS announcement does not contain any major news regarding the company's operations, financials, or strategic developments. It is simply a notification of a change in shareholding, which is a routine regulatory disclosure and does not significantly impact the company's outlook.
Key Points
- Optibiotix Health plc has reduced its stake in SkinBioTherapeutics from 8.46% to 7.95%
- The change in shareholding was notified to the company on 6 May 2025
Summary
The healthcare company has announced a change in its major shareholding, with Optibiotix Health plc reducing its stake in the business.
SkinBioTherapeutics plc has announced that Optibiotix Health plc has reduced its shareholding in the company from 8.46% to 7.95%. This change in major shareholding was notified to the company on 6 May 2025.
DIRECTOR DEALINGS